Apimeds Pharmaceuticals US, Inc.APUS
Apimeds Pharmaceuticals US, Inc., a healthcare name on NYSE.
Apimeds Pharmaceuticals US, Inc. (APUS) belongs to the healthcare sector, listed on NYSE operating in pharmaceutical preparations.
A descriptive overview for APUS is pending the next reference-data sync.
Stock Sensei's APUS activity, surfaced from the live alert stream.
Below is the outcome history for APUS from Stock Sensei's alert feed. Entry, target, and stop levels, plus the chart-level reasoning, are members-only.
- BUYOct 5, 2026Hit+36.52%
- BUYOct 5, 2026Hit+13.29%
Full details unlock inside the app
Common questions about this stock.
What is APUS?
APUS is the trading symbol for Apimeds Pharmaceuticals US, Inc., listed on NYSE in the healthcare sector.
What sector is APUS in?
Apimeds Pharmaceuticals US, Inc. (APUS) is classified in the healthcare sector, specifically pharmaceutical preparations, based on its SEC SIC classification.
Has Stock Sensei traded APUS?
Yes, APUS has appeared in the Stock Sensei alert feed 2 times, including 2 calls that hit target. The "Stock Sensei's calls on APUS" section above lists the recent history; entry, target, and stop levels are members-only.
Where does APUS trade?
APUS trades on NYSE.
Is APUS a stock or an ETF?
APUS is a publicly-traded common stock, not an ETF.
Trade APUS alongside Stock Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.